Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 1

Conditions

Skin Neoplasms 1Pancreatic Neoplasms 1Esophageal Neoplasms 1Cicatrix 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × abobotulinumtoxinA × Clear all
NCT04965311 2025-05-13

Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy

OHSU Knight Cancer Institute

Phase 2 Terminated
4 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

NCT02965976 2023-02-16

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
33 enrolled 17 charts
Gastrointestinal

Esophageal Neoplasms

NCT01459666 2022-05-26

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

University Hospitals Cleveland Medical Center

Phase 4 Terminated
9 enrolled 6 charts
Dermatologic

Cicatrix, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡